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BACKGROUND: Postoperative ileus (POI) is observed in 20-30% of patients
undergoing colorectal cancer surgery, despite enhanced recovery programs (ERPs).
Cyclooxygenase (COX)-2 is identified as a key enzyme in POI, but other arachidonic
acid pathway enzymes have received little attention despite their potential as
selective targets to prevent POI. The objectives were to compare the expression of
arachidonic acid metabolism (AAM) enzymes (1) between patients who underwent
colorectal cancer surgery and followed an ERP or not (NERP), (2) and between ERP
patients who experimented POI or not and (3) to determine the ability of
antagonists of these pathways to modulate contractile activity of colonic muscle.
METHODS: This was a translational study. Main outcome measures were
gastrointestinal motility recovery data, mRNA expressions of key enzymes involved
in AAM (RT-qPCR) and ex vivo motility values of the circular colon muscle. Twenty-
eight prospectively included ERP patients were compared to eleven retrospectively
included NERP patients that underwent colorectal cancer surgery.
RESULTS: ERP reduced colonic mucosal COX-2, microsomal prostaglandin E
synthase (mPGES1) and hematopoietic prostaglandin D synthase (HPGDS) mRNA
expression. mPGES1 and HPGDS mRNA expression were significantly associated
with ERP compliance (respectively, r2 = 0.25, p = 0.002 and r2 = 0.6, p < 0.001).
In muscularis propria, HPGDS mRNA expression was correlated with GI motility
recovery (p = 0.002). The pharmacological inhibition of mPGES1 increased
spontaneous ex vivo contractile activity in circular muscle (p = 0.03).
CONCLUSION: The effects of ERP on GI recovery are correlated with the
compliance of ERP and could be mediated at least in part by mPGES1, HPGDS and
COX-2. Furthermore, mPGES1 shows promise as a therapeutic target to further
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